Details for Patent: 6,884,434

Summary for Patent: 6,884,434

Title:	Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
Abstract:	A transdermal therapeutic system, comprising a backing layer inert to the components of the matrix, a self-adhesive matrix layer containing (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol in an effective amount and a protective foil or sheet to be removed prior to use, is characterised by a matrix that is based on a non-aqueous, acrylate-based or silicone-based polymer adhesive system having a solubility of .gtoreq.5% (w/w) for (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]-amino]-1-naphthaleno l, and said matrix is substantially free of inorganic silicate particulates.
Inventor(s):	Muller; Walter (Neuwied, DE), Peck; James V. (Richmond, VA)
Assignee:	LTS Lohmann Therapie-Systeme AG (Andernach, DE) Aderis Pharmaceuticals, Inc. (Richmond, VA)
Application Number:	09/647,290
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,884,434
Patent Claim Types: see list of patent claims	Use; Compound;

Drugs Protected by US Patent 6,884,434

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,884,434

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	198 14 084	Mar 30, 1998

PCT Information
PCT Filed	March 18, 1999	PCT Application Number:	PCT/EP99/01795
PCT Publication Date:	October 07, 1999	PCT Publication Number:	WO99/49852

International Family Members for US Patent 6,884,434

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	014778
Austria	210973
Australia	2934199
Australia	746856
Brazil	9909313
Canada	2326630
China	1142773